Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo

Overview of attention for article published in BMC Cancer, August 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 11,847 followers.

#pancreaticcancer Harima H, Kaino S, Takami T, Shinoda S, Matsumoto T, Fujisawa K, Yamamoto N, Yamasaki T, Sakaid… https://t.co/Tk5ZoPIbwv

RT @lgoodbu: Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro a... https://t.co…

Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro a... https://t.co/b6ZNpvu0iy

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.